VIEWPOINTS PharmaShots Interview: Amolyt Pharma’s Thierry Abribat Shares Insight on AZP-3601 for HypoparathyroidismBySenior EditorMay 10, 20210Comments
VIEWPOINTS PharmaShots Interview: J&J’s Sven Sjovall & Dr. Mark Watt Share Insight on Nicorette’s Latest Digital Smoking Cessation OfferingBySenior EditorMay 5, 20210Comments
VIEWPOINTS PharmaShots Interview: Dr. Drew Falconer Shares Insights on the Abbott’s NeuroSphere Virtual ClinicBySenior EditorMay 3, 20210Comments
VIEWPOINTS PharmaShots Interview: Dr. Robert Koenekoop Shares Insights on Stellar Study Evaluating ProQR’s QR-421aBySenior EditorMay 3, 20210Comments
THOUGHTSPOT Adjunctive Nutraceutical Therapies Supporting Immunity in COVID-19BySunaina AnandApril 28, 20210Comments
VIEWPOINTS PharmaShots Interview: Zealand Pharma’s Emmanuel Dulac Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Adult Patients with DiabetesBySenior EditorApril 28, 20210Comments
VIEWPOINTS PharmaShots Interview: Pyxis Oncology’s Dr. Lara S. Sullivan and Dr. Ronald Herbst Share Insights on the Importance of Series B Funding to Advance their PortfolioBySenior EditorApril 26, 20210Comments
